阿扎胞苷：一种与Sweet综合征相关的新药。 - Suppr

Azacitidine: a new medication associated with Sweet syndrome.

作者信息

Tintle Suzanne, Patel Vishal, Ruskin Andrea, Halasz Charles

出版信息

J Am Acad Dermatol. 2011 May;64(5):e77-9. doi: 10.1016/j.jaad.2010.06.032.

DOI:10.1016/j.jaad.2010.06.032

PMID:21496689

Abstract

摘要

相似文献

Azacitidine: a new medication associated with Sweet syndrome.

J Am Acad Dermatol. 2011 May;64(5):e77-9. doi: 10.1016/j.jaad.2010.06.032.

Histiocytoid Sweet's syndrome potentially related to decitabine in a patient with myelodysplastic syndrome.

Eur J Dermatol. 2012 Nov-Dec;22(6):811-2. doi: 10.1684/ejd.2012.1861.

Recurrence of abdominal large-vessel vasculitis and development of severe Sweet syndrome after a single cycle of 5-azacytidine in a patient with myelodysplastic syndrome.

Eur J Haematol. 2014 Apr;92(4):362-4. doi: 10.1111/ejh.12249. Epub 2014 Jan 10.

Atypical presentations of Sweet's syndrome in patients with MDS/AML receiving combinations of hypomethylating agents with histone deacetylase inhibitors.

Am J Hematol. 2009 Oct;84(10):688-9. doi: 10.1002/ajh.21510.

A case of polycyclic Sweet's syndrome arising from azacitidine injection sites in myelodysplasia.

Ann Hematol. 2020 Jan;99(1):201-202. doi: 10.1007/s00277-019-03873-x. Epub 2019 Dec 9.

Practical recommendations for hypomethylating agent therapy of patients with myelodysplastic syndromes.

Hematol Oncol Clin North Am. 2010 Apr;24(2):389-406. doi: 10.1016/j.hoc.2010.02.012.

[Effectiveness and safety of 5-azacitidine in three patients with myelodysplastic syndromes].

Farm Hosp. 2010 Jul-Aug;34(4):204-8. doi: 10.1016/j.farma.2009.11.003. Epub 2010 Feb 24.

Cutaneous reactions to azacitidine.

Arch Dermatol. 1991 Dec;127(12):1847-8.

Further analysis of trials with azacitidine in patients with myelodysplastic syndrome: studies 8421, 8921, and 9221 by the Cancer and Leukemia Group B.

J Clin Oncol. 2006 Aug 20;24(24):3895-903. doi: 10.1200/JCO.2005.05.4346.

FDA drug approval summary: azacitidine (5-azacytidine, Vidaza) for injectable suspension.

Oncologist. 2005 Mar;10(3):176-82. doi: 10.1634/theoncologist.10-3-176.

引用本文的文献

Painful Erythematous Plaques on the Hands: A Quiz.

Acta Derm Venereol. 2023 Jul 13;103:adv12344. doi: 10.2340/actadv.v103.12344.

Evaluation of Delayed-Type Hypersensitivity to Antineoplastic Drugs-An Overview.

Cancers (Basel). 2023 Feb 14;15(4):1208. doi: 10.3390/cancers15041208.

Insights Into the Pathogenesis of Sweet's Syndrome.

Front Immunol. 2019 Mar 12;10:414. doi: 10.3389/fimmu.2019.00414. eCollection 2019.

Sweet's syndrome associated with clonal hematopoiesis of indeterminate potential responsive to 5-azacitidine.

Ther Adv Hematol. 2017 Feb;8(2):91-95. doi: 10.1177/2040620716680330. Epub 2016 Nov 29.

Histiocytoid Variant of Sweet Syndrome Associated with Azacitidine and Recurrence upon Rechallenge.

Can J Hosp Pharm. 2015 Jul-Aug;68(4):339-41. doi: 10.4212/cjhp.v68i4.1475.

Complete remission of Sweet's syndrome after azacytidine treatment for concomitant myelodysplastic syndrome.

Int J Hematol. 2014;99(5):663-7. doi: 10.1007/s12185-014-1527-9. Epub 2014 Feb 20.

Use of azacitidine for myelodysplastic syndromes: controversial issues and practical recommendations.

Blood Res. 2013 Jun;48(2):87-98. doi: 10.5045/br.2013.48.2.87. Epub 2013 Jun 25.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Azacitidine: a new medication associated with Sweet syndrome.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献